Global Hereditary Disease Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Hereditary Disease Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Hereditary Disease Testing industry chain, the market status of Hospital (Hereditary Cancer Testing, Hereditary Non-cancer Testing), Clinic (Hereditary Cancer Testing, Hereditary Non-cancer Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hereditary Disease Testing.
Regionally, the report analyzes the Hereditary Disease Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hereditary Disease Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hereditary Disease Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hereditary Disease Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hereditary Cancer Testing, Hereditary Non-cancer Testing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hereditary Disease Testing market.
Regional Analysis: The report involves examining the Hereditary Disease Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hereditary Disease Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hereditary Disease Testing:
Company Analysis: Report covers individual Hereditary Disease Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hereditary Disease Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Hereditary Disease Testing. It assesses the current state, advancements, and potential future developments in Hereditary Disease Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hereditary Disease Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hereditary Disease Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Hereditary Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hereditary Disease Testing, with revenue, gross margin and global market share of Hereditary Disease Testing from 2018 to 2023.
Chapter 3, the Hereditary Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hereditary Disease Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Disease Testing.
Chapter 13, to describe Hereditary Disease Testing research findings and conclusion.
The Global Info Research report includes an overview of the development of the Hereditary Disease Testing industry chain, the market status of Hospital (Hereditary Cancer Testing, Hereditary Non-cancer Testing), Clinic (Hereditary Cancer Testing, Hereditary Non-cancer Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hereditary Disease Testing.
Regionally, the report analyzes the Hereditary Disease Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hereditary Disease Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hereditary Disease Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hereditary Disease Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hereditary Cancer Testing, Hereditary Non-cancer Testing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hereditary Disease Testing market.
Regional Analysis: The report involves examining the Hereditary Disease Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hereditary Disease Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hereditary Disease Testing:
Company Analysis: Report covers individual Hereditary Disease Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hereditary Disease Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Hereditary Disease Testing. It assesses the current state, advancements, and potential future developments in Hereditary Disease Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hereditary Disease Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hereditary Disease Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Hereditary Cancer Testing
- Hereditary Non-cancer Testing
- Hospital
- Clinic
- Laboratory
- Others
- Myriad Genetics
- Invitae
- Illumina
- Natera
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche
- Quest Diagnostics
- CooperSurgical
- Agilent Technologies
- Thermo Fisher Scientific
- Twist Bioscience
- Sophia Genetics
- Fulgent Genetic
- Medgenome
- CENTOGENE
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Hereditary Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hereditary Disease Testing, with revenue, gross margin and global market share of Hereditary Disease Testing from 2018 to 2023.
Chapter 3, the Hereditary Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hereditary Disease Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Disease Testing.
Chapter 13, to describe Hereditary Disease Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Hereditary Disease Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hereditary Disease Testing by Type
1.3.1 Overview: Global Hereditary Disease Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Hereditary Disease Testing Consumption Value Market Share by Type in 2022
1.3.3 Hereditary Cancer Testing
1.3.4 Hereditary Non-cancer Testing
1.4 Global Hereditary Disease Testing Market by Application
1.4.1 Overview: Global Hereditary Disease Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Laboratory
1.4.5 Others
1.5 Global Hereditary Disease Testing Market Size & Forecast
1.6 Global Hereditary Disease Testing Market Size and Forecast by Region
1.6.1 Global Hereditary Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Hereditary Disease Testing Market Size by Region, (2018-2029)
1.6.3 North America Hereditary Disease Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Hereditary Disease Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Hereditary Disease Testing Market Size and Prospect (2018-2029)
1.6.6 South America Hereditary Disease Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Hereditary Disease Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Myriad Genetics
2.1.1 Myriad Genetics Details
2.1.2 Myriad Genetics Major Business
2.1.3 Myriad Genetics Hereditary Disease Testing Product and Solutions
2.1.4 Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Myriad Genetics Recent Developments and Future Plans
2.2 Invitae
2.2.1 Invitae Details
2.2.2 Invitae Major Business
2.2.3 Invitae Hereditary Disease Testing Product and Solutions
2.2.4 Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Invitae Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Hereditary Disease Testing Product and Solutions
2.3.4 Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Natera
2.4.1 Natera Details
2.4.2 Natera Major Business
2.4.3 Natera Hereditary Disease Testing Product and Solutions
2.4.4 Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Natera Recent Developments and Future Plans
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business
2.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
2.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business
2.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
2.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business
2.7.3 Quest Diagnostics Hereditary Disease Testing Product and Solutions
2.7.4 Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Quest Diagnostics Recent Developments and Future Plans
2.8 CooperSurgical
2.8.1 CooperSurgical Details
2.8.2 CooperSurgical Major Business
2.8.3 CooperSurgical Hereditary Disease Testing Product and Solutions
2.8.4 CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CooperSurgical Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Hereditary Disease Testing Product and Solutions
2.9.4 Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Thermo Fisher Scientific
2.10.1 Thermo Fisher Scientific Details
2.10.2 Thermo Fisher Scientific Major Business
2.10.3 Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
2.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.11 Twist Bioscience
2.11.1 Twist Bioscience Details
2.11.2 Twist Bioscience Major Business
2.11.3 Twist Bioscience Hereditary Disease Testing Product and Solutions
2.11.4 Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Twist Bioscience Recent Developments and Future Plans
2.12 Sophia Genetics
2.12.1 Sophia Genetics Details
2.12.2 Sophia Genetics Major Business
2.12.3 Sophia Genetics Hereditary Disease Testing Product and Solutions
2.12.4 Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sophia Genetics Recent Developments and Future Plans
2.13 Fulgent Genetic
2.13.1 Fulgent Genetic Details
2.13.2 Fulgent Genetic Major Business
2.13.3 Fulgent Genetic Hereditary Disease Testing Product and Solutions
2.13.4 Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Fulgent Genetic Recent Developments and Future Plans
2.14 Medgenome
2.14.1 Medgenome Details
2.14.2 Medgenome Major Business
2.14.3 Medgenome Hereditary Disease Testing Product and Solutions
2.14.4 Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Medgenome Recent Developments and Future Plans
2.15 CENTOGENE
2.15.1 CENTOGENE Details
2.15.2 CENTOGENE Major Business
2.15.3 CENTOGENE Hereditary Disease Testing Product and Solutions
2.15.4 CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 CENTOGENE Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hereditary Disease Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Hereditary Disease Testing by Company Revenue
3.2.2 Top 3 Hereditary Disease Testing Players Market Share in 2022
3.2.3 Top 6 Hereditary Disease Testing Players Market Share in 2022
3.3 Hereditary Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Hereditary Disease Testing Market: Region Footprint
3.3.2 Hereditary Disease Testing Market: Company Product Type Footprint
3.3.3 Hereditary Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hereditary Disease Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Hereditary Disease Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hereditary Disease Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Hereditary Disease Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Hereditary Disease Testing Consumption Value by Type (2018-2029)
6.2 North America Hereditary Disease Testing Consumption Value by Application (2018-2029)
6.3 North America Hereditary Disease Testing Market Size by Country
6.3.1 North America Hereditary Disease Testing Consumption Value by Country (2018-2029)
6.3.2 United States Hereditary Disease Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Hereditary Disease Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Hereditary Disease Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Hereditary Disease Testing Consumption Value by Type (2018-2029)
7.2 Europe Hereditary Disease Testing Consumption Value by Application (2018-2029)
7.3 Europe Hereditary Disease Testing Market Size by Country
7.3.1 Europe Hereditary Disease Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Hereditary Disease Testing Market Size and Forecast (2018-2029)
7.3.3 France Hereditary Disease Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Hereditary Disease Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Hereditary Disease Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Hereditary Disease Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Hereditary Disease Testing Market Size by Region
8.3.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2018-2029)
8.3.2 China Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.5 India Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Hereditary Disease Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Hereditary Disease Testing Consumption Value by Type (2018-2029)
9.2 South America Hereditary Disease Testing Consumption Value by Application (2018-2029)
9.3 South America Hereditary Disease Testing Market Size by Country
9.3.1 South America Hereditary Disease Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Hereditary Disease Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Hereditary Disease Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Hereditary Disease Testing Market Size by Country
10.3.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Hereditary Disease Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Hereditary Disease Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Hereditary Disease Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Hereditary Disease Testing Market Drivers
11.2 Hereditary Disease Testing Market Restraints
11.3 Hereditary Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hereditary Disease Testing Industry Chain
12.2 Hereditary Disease Testing Upstream Analysis
12.3 Hereditary Disease Testing Midstream Analysis
12.4 Hereditary Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Hereditary Disease Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hereditary Disease Testing by Type
1.3.1 Overview: Global Hereditary Disease Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Hereditary Disease Testing Consumption Value Market Share by Type in 2022
1.3.3 Hereditary Cancer Testing
1.3.4 Hereditary Non-cancer Testing
1.4 Global Hereditary Disease Testing Market by Application
1.4.1 Overview: Global Hereditary Disease Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Laboratory
1.4.5 Others
1.5 Global Hereditary Disease Testing Market Size & Forecast
1.6 Global Hereditary Disease Testing Market Size and Forecast by Region
1.6.1 Global Hereditary Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Hereditary Disease Testing Market Size by Region, (2018-2029)
1.6.3 North America Hereditary Disease Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Hereditary Disease Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Hereditary Disease Testing Market Size and Prospect (2018-2029)
1.6.6 South America Hereditary Disease Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Hereditary Disease Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Myriad Genetics
2.1.1 Myriad Genetics Details
2.1.2 Myriad Genetics Major Business
2.1.3 Myriad Genetics Hereditary Disease Testing Product and Solutions
2.1.4 Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Myriad Genetics Recent Developments and Future Plans
2.2 Invitae
2.2.1 Invitae Details
2.2.2 Invitae Major Business
2.2.3 Invitae Hereditary Disease Testing Product and Solutions
2.2.4 Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Invitae Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Hereditary Disease Testing Product and Solutions
2.3.4 Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Natera
2.4.1 Natera Details
2.4.2 Natera Major Business
2.4.3 Natera Hereditary Disease Testing Product and Solutions
2.4.4 Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Natera Recent Developments and Future Plans
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business
2.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
2.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business
2.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
2.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business
2.7.3 Quest Diagnostics Hereditary Disease Testing Product and Solutions
2.7.4 Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Quest Diagnostics Recent Developments and Future Plans
2.8 CooperSurgical
2.8.1 CooperSurgical Details
2.8.2 CooperSurgical Major Business
2.8.3 CooperSurgical Hereditary Disease Testing Product and Solutions
2.8.4 CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CooperSurgical Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Hereditary Disease Testing Product and Solutions
2.9.4 Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Thermo Fisher Scientific
2.10.1 Thermo Fisher Scientific Details
2.10.2 Thermo Fisher Scientific Major Business
2.10.3 Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
2.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.11 Twist Bioscience
2.11.1 Twist Bioscience Details
2.11.2 Twist Bioscience Major Business
2.11.3 Twist Bioscience Hereditary Disease Testing Product and Solutions
2.11.4 Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Twist Bioscience Recent Developments and Future Plans
2.12 Sophia Genetics
2.12.1 Sophia Genetics Details
2.12.2 Sophia Genetics Major Business
2.12.3 Sophia Genetics Hereditary Disease Testing Product and Solutions
2.12.4 Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sophia Genetics Recent Developments and Future Plans
2.13 Fulgent Genetic
2.13.1 Fulgent Genetic Details
2.13.2 Fulgent Genetic Major Business
2.13.3 Fulgent Genetic Hereditary Disease Testing Product and Solutions
2.13.4 Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Fulgent Genetic Recent Developments and Future Plans
2.14 Medgenome
2.14.1 Medgenome Details
2.14.2 Medgenome Major Business
2.14.3 Medgenome Hereditary Disease Testing Product and Solutions
2.14.4 Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Medgenome Recent Developments and Future Plans
2.15 CENTOGENE
2.15.1 CENTOGENE Details
2.15.2 CENTOGENE Major Business
2.15.3 CENTOGENE Hereditary Disease Testing Product and Solutions
2.15.4 CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 CENTOGENE Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hereditary Disease Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Hereditary Disease Testing by Company Revenue
3.2.2 Top 3 Hereditary Disease Testing Players Market Share in 2022
3.2.3 Top 6 Hereditary Disease Testing Players Market Share in 2022
3.3 Hereditary Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Hereditary Disease Testing Market: Region Footprint
3.3.2 Hereditary Disease Testing Market: Company Product Type Footprint
3.3.3 Hereditary Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hereditary Disease Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Hereditary Disease Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hereditary Disease Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Hereditary Disease Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Hereditary Disease Testing Consumption Value by Type (2018-2029)
6.2 North America Hereditary Disease Testing Consumption Value by Application (2018-2029)
6.3 North America Hereditary Disease Testing Market Size by Country
6.3.1 North America Hereditary Disease Testing Consumption Value by Country (2018-2029)
6.3.2 United States Hereditary Disease Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Hereditary Disease Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Hereditary Disease Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Hereditary Disease Testing Consumption Value by Type (2018-2029)
7.2 Europe Hereditary Disease Testing Consumption Value by Application (2018-2029)
7.3 Europe Hereditary Disease Testing Market Size by Country
7.3.1 Europe Hereditary Disease Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Hereditary Disease Testing Market Size and Forecast (2018-2029)
7.3.3 France Hereditary Disease Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Hereditary Disease Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Hereditary Disease Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Hereditary Disease Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Hereditary Disease Testing Market Size by Region
8.3.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2018-2029)
8.3.2 China Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.5 India Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Hereditary Disease Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Hereditary Disease Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Hereditary Disease Testing Consumption Value by Type (2018-2029)
9.2 South America Hereditary Disease Testing Consumption Value by Application (2018-2029)
9.3 South America Hereditary Disease Testing Market Size by Country
9.3.1 South America Hereditary Disease Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Hereditary Disease Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Hereditary Disease Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Hereditary Disease Testing Market Size by Country
10.3.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Hereditary Disease Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Hereditary Disease Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Hereditary Disease Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Hereditary Disease Testing Market Drivers
11.2 Hereditary Disease Testing Market Restraints
11.3 Hereditary Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hereditary Disease Testing Industry Chain
12.2 Hereditary Disease Testing Upstream Analysis
12.3 Hereditary Disease Testing Midstream Analysis
12.4 Hereditary Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hereditary Disease Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Hereditary Disease Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Hereditary Disease Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 6. Myriad Genetics Major Business
Table 7. Myriad Genetics Hereditary Disease Testing Product and Solutions
Table 8. Myriad Genetics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Myriad Genetics Recent Developments and Future Plans
Table 10. Invitae Company Information, Head Office, and Major Competitors
Table 11. Invitae Major Business
Table 12. Invitae Hereditary Disease Testing Product and Solutions
Table 13. Invitae Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Invitae Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Hereditary Disease Testing Product and Solutions
Table 18. Illumina Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Natera Company Information, Head Office, and Major Competitors
Table 21. Natera Major Business
Table 22. Natera Hereditary Disease Testing Product and Solutions
Table 23. Natera Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Natera Recent Developments and Future Plans
Table 25. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 26. Laboratory Corporation of America Holdings Major Business
Table 27. Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
Table 28. Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 30. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 31. F. Hoffmann-La Roche Major Business
Table 32. F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
Table 33. F. Hoffmann-La Roche Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 35. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 36. Quest Diagnostics Major Business
Table 37. Quest Diagnostics Hereditary Disease Testing Product and Solutions
Table 38. Quest Diagnostics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Quest Diagnostics Recent Developments and Future Plans
Table 40. CooperSurgical Company Information, Head Office, and Major Competitors
Table 41. CooperSurgical Major Business
Table 42. CooperSurgical Hereditary Disease Testing Product and Solutions
Table 43. CooperSurgical Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. CooperSurgical Recent Developments and Future Plans
Table 45. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 46. Agilent Technologies Major Business
Table 47. Agilent Technologies Hereditary Disease Testing Product and Solutions
Table 48. Agilent Technologies Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Agilent Technologies Recent Developments and Future Plans
Table 50. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 51. Thermo Fisher Scientific Major Business
Table 52. Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
Table 53. Thermo Fisher Scientific Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Thermo Fisher Scientific Recent Developments and Future Plans
Table 55. Twist Bioscience Company Information, Head Office, and Major Competitors
Table 56. Twist Bioscience Major Business
Table 57. Twist Bioscience Hereditary Disease Testing Product and Solutions
Table 58. Twist Bioscience Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Twist Bioscience Recent Developments and Future Plans
Table 60. Sophia Genetics Company Information, Head Office, and Major Competitors
Table 61. Sophia Genetics Major Business
Table 62. Sophia Genetics Hereditary Disease Testing Product and Solutions
Table 63. Sophia Genetics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Sophia Genetics Recent Developments and Future Plans
Table 65. Fulgent Genetic Company Information, Head Office, and Major Competitors
Table 66. Fulgent Genetic Major Business
Table 67. Fulgent Genetic Hereditary Disease Testing Product and Solutions
Table 68. Fulgent Genetic Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Fulgent Genetic Recent Developments and Future Plans
Table 70. Medgenome Company Information, Head Office, and Major Competitors
Table 71. Medgenome Major Business
Table 72. Medgenome Hereditary Disease Testing Product and Solutions
Table 73. Medgenome Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Medgenome Recent Developments and Future Plans
Table 75. CENTOGENE Company Information, Head Office, and Major Competitors
Table 76. CENTOGENE Major Business
Table 77. CENTOGENE Hereditary Disease Testing Product and Solutions
Table 78. CENTOGENE Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. CENTOGENE Recent Developments and Future Plans
Table 80. Global Hereditary Disease Testing Revenue (USD Million) by Players (2018-2023)
Table 81. Global Hereditary Disease Testing Revenue Share by Players (2018-2023)
Table 82. Breakdown of Hereditary Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Hereditary Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Hereditary Disease Testing Players
Table 85. Hereditary Disease Testing Market: Company Product Type Footprint
Table 86. Hereditary Disease Testing Market: Company Product Application Footprint
Table 87. Hereditary Disease Testing New Market Entrants and Barriers to Market Entry
Table 88. Hereditary Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Hereditary Disease Testing Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Hereditary Disease Testing Consumption Value Share by Type (2018-2023)
Table 91. Global Hereditary Disease Testing Consumption Value Forecast by Type (2024-2029)
Table 92. Global Hereditary Disease Testing Consumption Value by Application (2018-2023)
Table 93. Global Hereditary Disease Testing Consumption Value Forecast by Application (2024-2029)
Table 94. North America Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Hereditary Disease Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Hereditary Disease Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Hereditary Disease Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Hereditary Disease Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Hereditary Disease Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Hereditary Disease Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Hereditary Disease Testing Raw Material
Table 125. Key Suppliers of Hereditary Disease Testing Raw Materials
Table 1. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hereditary Disease Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Hereditary Disease Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Hereditary Disease Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 6. Myriad Genetics Major Business
Table 7. Myriad Genetics Hereditary Disease Testing Product and Solutions
Table 8. Myriad Genetics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Myriad Genetics Recent Developments and Future Plans
Table 10. Invitae Company Information, Head Office, and Major Competitors
Table 11. Invitae Major Business
Table 12. Invitae Hereditary Disease Testing Product and Solutions
Table 13. Invitae Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Invitae Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Hereditary Disease Testing Product and Solutions
Table 18. Illumina Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Natera Company Information, Head Office, and Major Competitors
Table 21. Natera Major Business
Table 22. Natera Hereditary Disease Testing Product and Solutions
Table 23. Natera Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Natera Recent Developments and Future Plans
Table 25. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 26. Laboratory Corporation of America Holdings Major Business
Table 27. Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
Table 28. Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 30. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 31. F. Hoffmann-La Roche Major Business
Table 32. F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
Table 33. F. Hoffmann-La Roche Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 35. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 36. Quest Diagnostics Major Business
Table 37. Quest Diagnostics Hereditary Disease Testing Product and Solutions
Table 38. Quest Diagnostics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Quest Diagnostics Recent Developments and Future Plans
Table 40. CooperSurgical Company Information, Head Office, and Major Competitors
Table 41. CooperSurgical Major Business
Table 42. CooperSurgical Hereditary Disease Testing Product and Solutions
Table 43. CooperSurgical Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. CooperSurgical Recent Developments and Future Plans
Table 45. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 46. Agilent Technologies Major Business
Table 47. Agilent Technologies Hereditary Disease Testing Product and Solutions
Table 48. Agilent Technologies Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Agilent Technologies Recent Developments and Future Plans
Table 50. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 51. Thermo Fisher Scientific Major Business
Table 52. Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
Table 53. Thermo Fisher Scientific Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Thermo Fisher Scientific Recent Developments and Future Plans
Table 55. Twist Bioscience Company Information, Head Office, and Major Competitors
Table 56. Twist Bioscience Major Business
Table 57. Twist Bioscience Hereditary Disease Testing Product and Solutions
Table 58. Twist Bioscience Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Twist Bioscience Recent Developments and Future Plans
Table 60. Sophia Genetics Company Information, Head Office, and Major Competitors
Table 61. Sophia Genetics Major Business
Table 62. Sophia Genetics Hereditary Disease Testing Product and Solutions
Table 63. Sophia Genetics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Sophia Genetics Recent Developments and Future Plans
Table 65. Fulgent Genetic Company Information, Head Office, and Major Competitors
Table 66. Fulgent Genetic Major Business
Table 67. Fulgent Genetic Hereditary Disease Testing Product and Solutions
Table 68. Fulgent Genetic Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Fulgent Genetic Recent Developments and Future Plans
Table 70. Medgenome Company Information, Head Office, and Major Competitors
Table 71. Medgenome Major Business
Table 72. Medgenome Hereditary Disease Testing Product and Solutions
Table 73. Medgenome Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Medgenome Recent Developments and Future Plans
Table 75. CENTOGENE Company Information, Head Office, and Major Competitors
Table 76. CENTOGENE Major Business
Table 77. CENTOGENE Hereditary Disease Testing Product and Solutions
Table 78. CENTOGENE Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. CENTOGENE Recent Developments and Future Plans
Table 80. Global Hereditary Disease Testing Revenue (USD Million) by Players (2018-2023)
Table 81. Global Hereditary Disease Testing Revenue Share by Players (2018-2023)
Table 82. Breakdown of Hereditary Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Hereditary Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Hereditary Disease Testing Players
Table 85. Hereditary Disease Testing Market: Company Product Type Footprint
Table 86. Hereditary Disease Testing Market: Company Product Application Footprint
Table 87. Hereditary Disease Testing New Market Entrants and Barriers to Market Entry
Table 88. Hereditary Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Hereditary Disease Testing Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Hereditary Disease Testing Consumption Value Share by Type (2018-2023)
Table 91. Global Hereditary Disease Testing Consumption Value Forecast by Type (2024-2029)
Table 92. Global Hereditary Disease Testing Consumption Value by Application (2018-2023)
Table 93. Global Hereditary Disease Testing Consumption Value Forecast by Application (2024-2029)
Table 94. North America Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Hereditary Disease Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Hereditary Disease Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Hereditary Disease Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Hereditary Disease Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Hereditary Disease Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Hereditary Disease Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Hereditary Disease Testing Raw Material
Table 125. Key Suppliers of Hereditary Disease Testing Raw Materials
LIST OF FIGURES
Figure 1. Hereditary Disease Testing Picture
Figure 2. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hereditary Disease Testing Consumption Value Market Share by Type in 2022
Figure 4. Hereditary Cancer Testing
Figure 5. Hereditary Non-cancer Testing
Figure 6. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Hereditary Disease Testing Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Laboratory Picture
Figure 11. Others Picture
Figure 12. Global Hereditary Disease Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Hereditary Disease Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Hereditary Disease Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Hereditary Disease Testing Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Hereditary Disease Testing Consumption Value Market Share by Region in 2022
Figure 17. North America Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Hereditary Disease Testing Revenue Share by Players in 2022
Figure 23. Hereditary Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Hereditary Disease Testing Market Share in 2022
Figure 25. Global Top 6 Players Hereditary Disease Testing Market Share in 2022
Figure 26. Global Hereditary Disease Testing Consumption Value Share by Type (2018-2023)
Figure 27. Global Hereditary Disease Testing Market Share Forecast by Type (2024-2029)
Figure 28. Global Hereditary Disease Testing Consumption Value Share by Application (2018-2023)
Figure 29. Global Hereditary Disease Testing Market Share Forecast by Application (2024-2029)
Figure 30. North America Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Hereditary Disease Testing Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Hereditary Disease Testing Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. France Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Region (2018-2029)
Figure 47. China Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. India Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Hereditary Disease Testing Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Hereditary Disease Testing Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 64. Hereditary Disease Testing Market Drivers
Figure 65. Hereditary Disease Testing Market Restraints
Figure 66. Hereditary Disease Testing Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Hereditary Disease Testing in 2022
Figure 69. Manufacturing Process Analysis of Hereditary Disease Testing
Figure 70. Hereditary Disease Testing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Hereditary Disease Testing Picture
Figure 2. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hereditary Disease Testing Consumption Value Market Share by Type in 2022
Figure 4. Hereditary Cancer Testing
Figure 5. Hereditary Non-cancer Testing
Figure 6. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Hereditary Disease Testing Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Laboratory Picture
Figure 11. Others Picture
Figure 12. Global Hereditary Disease Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Hereditary Disease Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Hereditary Disease Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Hereditary Disease Testing Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Hereditary Disease Testing Consumption Value Market Share by Region in 2022
Figure 17. North America Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Hereditary Disease Testing Revenue Share by Players in 2022
Figure 23. Hereditary Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Hereditary Disease Testing Market Share in 2022
Figure 25. Global Top 6 Players Hereditary Disease Testing Market Share in 2022
Figure 26. Global Hereditary Disease Testing Consumption Value Share by Type (2018-2023)
Figure 27. Global Hereditary Disease Testing Market Share Forecast by Type (2024-2029)
Figure 28. Global Hereditary Disease Testing Consumption Value Share by Application (2018-2023)
Figure 29. Global Hereditary Disease Testing Market Share Forecast by Application (2024-2029)
Figure 30. North America Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Hereditary Disease Testing Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Hereditary Disease Testing Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. France Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Region (2018-2029)
Figure 47. China Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. India Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Hereditary Disease Testing Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Hereditary Disease Testing Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Hereditary Disease Testing Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Hereditary Disease Testing Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Hereditary Disease Testing Consumption Value (2018-2029) & (USD Million)
Figure 64. Hereditary Disease Testing Market Drivers
Figure 65. Hereditary Disease Testing Market Restraints
Figure 66. Hereditary Disease Testing Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Hereditary Disease Testing in 2022
Figure 69. Manufacturing Process Analysis of Hereditary Disease Testing
Figure 70. Hereditary Disease Testing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
